SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of a new Phase II clinical trial, CLEANVLU2.
Emory Health Taps DrFirst to Leverage Clinical-Grade AI for Medication Adherence & Affordability
What You Should Know: – Emory Healthcare, a comprehensive academic health system in Georgia, is collaborating with healthcare technology pioneer DrFirst to help patients access